Cargando…

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein

Analysis of cerebrospinal fluid (CSF) is important for diagnosis of neurological diseases. Especially for neurodegenerative diseases, abnormal protein abundance in CSF is an important biomarker. However, the quality of CSF is a key factor for the analytic outcome. Any external contamination has trem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barkovits, Katalin, Kruse, Niels, Linden, Andreas, Tönges, Lars, Pfeiffer, Kathy, Mollenhauer, Brit, Marcus, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072133/ https://www.ncbi.nlm.nih.gov/pubmed/32033488 http://dx.doi.org/10.3390/cells9020370

Ejemplares similares

Quality Control—A Stepchild in Quantitative Proteomics: A Case Study for the Human CSF Proteome
por: Rozanova, Svitlana, et al.
Publicado: (2023)

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
por: Abdi, Ilham Y., et al.
Publicado: (2021)

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
por: Stuendl, Anne, et al.
Publicado: (2016)

Metabolic profiling of body fluids and multivariate data analysis
por: Trezzi, Jean-Pierre, et al.
Publicado: (2017)

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2017)

Dataset containing physiological amounts of spike-in proteins into murine C2C12 background as a ground truth quantitative LC-MS/MS reference
por: Uszkoreit, Julian, et al.
Publicado: (2022)

Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
por: Lázaro, Diana F., et al.
Publicado: (2014)

CSF Diagnostics: A Potentially Valuable Tool in Neurodegenerative and Inflammatory Disorders Involving Motor Neurons: A Review
por: Krause, Karsten, et al.
Publicado: (2021)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

Reproducibility, Specificity and Accuracy of Relative Quantification Using Spectral Library-based Data-independent Acquisition
por: Barkovits, Katalin, et al.
Publicado: (2020)

Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19
por: Wolny, Monika, et al.
Publicado: (2023)

Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research
por: Schilde, Lukas M., et al.
Publicado: (2018)

Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein
por: Höllerhage, Matthias, et al.
Publicado: (2022)

Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC
por: Ruf, Viktoria C., et al.
Publicado: (2020)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid
por: Kruse, Niels, et al.
Publicado: (2016)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation
por: Carboni, Eleonora, et al.
Publicado: (2017)

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease
por: Tönges, Lars, et al.
Publicado: (2014)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
por: Emdina, Anna, et al.
Publicado: (2022)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
por: Kruse, Niels, et al.
Publicado: (2018)

Glucocorticoid receptor complexes form cooperatively with the Hsp90 co-chaperones Pp5 and FKBPs
por: Kaziales, Anna, et al.
Publicado: (2020)

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
por: Chiasserini, Davide, et al.
Publicado: (2017)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
por: Poggiolini, Ilaria, et al.
Publicado: (2021)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
por: Blanco-Palmero, V. A., et al.
Publicado: (2021)

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
por: Oliveira, Luis M. A., et al.
Publicado: (2021)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
por: Kunadt, Marcel, et al.
Publicado: (2015)

SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
por: Zhu, Lin-nan, et al.
Publicado: (2018)

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
por: Eidson, Lori N., et al.
Publicado: (2017)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
por: Majbour, Nour K., et al.
Publicado: (2017)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
por: Boiten, Walter A., et al.
Publicado: (2020)

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies
por: Brockmann, Kathrin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5jk6lr1ilegb8osb5t6q5237k